Inflammatory Bowel Diseases and Multiple Sclerosis

ìpAWÐ
âõAo} / uBë ðùî / yíBoû 3 / KBüýr 3831
Aq@ðñl Þú AuP×Bkû Aq kAoôøBÿ Âl ||a|-FNT |(ìBðñl |bamixilfni|) ko
OõWýú oôAGÈ ìõWõk ko kuQ ðývQ(11 ,01). |Aq ÆpÖþ ârAoyùB cBÞþ
WùQ
ÞBÖþ AÆçÎBR AìB Þpk. AyBoû gõkAüíñþ AgPçæR GB @ðùB
Aüò k ô GýíBoÿ, Aq ðËp ÎõAìê qìýñú|Aÿ, kAoAÿ ô Wõû ìzPpÞþ
ìþ|GByñl Þú Aq Wíéú @ðùB ìþ|OõAó Gú OõqüÐ ðtAkÿ, uñþ ô øípAøþ
GýíBoAó ìB uBGÛú gBðõAkâþ ìõèPýLê Außépôq ô GýíBoüùBÿ AèPùBGþ
oôkû oA mÞp ðíþ|Þpkðl.
AuPÏlAk Gú GýíBoÿ ìõèPýLê Außépôq ðÛzþ ðlAoðl(7) . øýa|üà Aq
AÖrAü{
|ko |)2DON( Þpôó GýíBoÿ ko ìvEõë sðùBÿ Þú yl külû
Îéþ|oÒî Aüñßú uBèùB ÚHê, AoOHBÉ gBðõAkâþ Gýò GýíBoüùBÿ
AèPùBGþ oôkû ô ìõèPýLê Außépôq ìõok OõWú ÚpAo âpÖQ(6) , GÏløB
GýíBoüùBÿ AèPùBGþ oôkû ðýr ko øp k ô GýíBo Gú|gõGþ Gú koìBó KBui
kAkðl.
ÖpôÞ{ )gnittimer dna gnispaler( |øípAû Gõk. øýa|ÞlAï Aq
GýíBoAó ðBOõAðBüýùBÿ οHþ øípAû ðlAyPñl. ÎçDî ìpGõÉ Gú
gõGþ kAok(2) . uýp GýíBoÿ ìõèPýLê Außépôq ko øpk ô GýíBo ìB GB Îõk ô
@âùþ
Ký{ oôkû AèPùBGþ GýíBoüùBÿ Gú ìHPç GýíBoAó ko Außépôq
kÞPp AGpAøýíþ koüBðþ ô øíßBoAó
ìPh¿¿ýò ÚpAoâýpk(9,1) .
Außépôq ô øí`ñýò øñãBï Gpôq ÎçDî âõAoyþ-oôkû|Aÿ ìrìò ko
ìHPçüBó Gú ìõèPýLê Außépôq, GpouýùBÿ KBoAÞéýñýßþ ìõok ðËp
GB OõWú Gú ìÇBèI ÖõÝ, Aüò ðßPú cBDr AøíýQ AuQ Þú ko uýp
GBèýñþ GýíBoüùBÿ AèPùBGþ oôkû, ÎçDî οHþ ìÇp f|Þññlû ìõèPýLê
|AuP×Bkû ðíþ|Þpkðl; ÖpÂýú Aôë Þú ko ðùBüQ GýBðãp oAGÇú GýíBoüùBÿ
AèPùBGþ oôkû ô ìõèPýLê AußépôqAuQ GýzPpìþ|OõAðl ìõok OõWú ÚpAoâýpk.
ìvPÛýî ì¿pÙ Aüò kAoôøB kAðvQ. cBë, GB OõWú Gú Aüñßú AÞTpüQ
GýíBoAó ârAo} ylû ko ìÛBæR ìhPéØ Aq kAoôøBÿ Âl |a|-FNT
ìþ|OõAðl Gú ôAuÇú ì¿pÙ kAoôøBüþ øí`õó |bamixilfni |AÖrAü{
üBGl. Gp AuBx ÖpÂýú k ôï ìõèPýLê Außépôq oA ìþ|OõAó ÎBoÂú
Gú Aüò ìvEéú ìþ|OõAó k ô ÖpÂýú ìP×BôR oA ìÇp f Þpk: GpAuBx ÖpÂýú
Aôë Gpôq ìõèPýLê Außépôq ko ìHPçüBó Gú GýíBoüùBÿ AèPùBGþ oôkû
ìõèPýLê Außépôq ðýr kAoðl, Aq Aüò kAoôøB AuP×Bkû ðzõk(31) . GB OõWú
øírìBó
Þú oôkû AèPùBGþ GýíBoüùBÿ Gú ìHPç GýíBoAó ko AuQ ylû
kìýéýñýrAó yHýú Gú ìõèPýLê Außépôq yõk(21) . Gú øíýò kèýê Oõ¾ýú
AèPùBGBR
Gpôq Gú ìñXp ìþ|OõAðl oôkû AèPùBGþ GýíBoüùBÿ Gú ìHPçüBó
1. Rang EH, Brooke BN, Hermon-taylor J. Association of
ulcerative colitis with multiuple sclerosis[letter]. lancet
1982; 2: 555.
2. Keiko K, Hunter SF, Tholander MS et al. Concurrence of
inflammatory bowel disease and multiple sclerosis. Mayo
Clin Proc 2000; 75: 802-6.
3. Kitchin LI, Knobler RL, Friedman LS. Crohn's disease in a
patient with multiple sclerosis. J Clin Gastroenterol 1991;
13: 331-4.
4. Bussino GP, Corrente G, visiniti D. Crohn's disease and
multiple sclerosis: a single case report. Ital J Neurol Sci
1994; 15: 303-6.
5. Agranoff D, schon F. Are focal white matter lesions in
patients with inflammatory bowel disease linked to multiple
sclerosis [letter]. Lancet 1995; 346: 190-1.
6. Minuk GY, Lewkonia RM. Possible familial association of
multiple sclerosis and inflammatory bowel disease[letter]. N
Eng J Med 1986; 314: 586.
7. Sawcer S, Maranian M, Hensiek A et al. Crohn's associated
NOD2 gene variants are not involved in determining susceptibility
to multiple sclerosis. J Neurol Neurosurg Psychiatry
2003; 74: 1157.
8. Lossos A, River Y, Eliamkim A et al. Neurological aspects of
inflammatory bowel disease. Neurology 1995; 45: 416-21.
9. Pandian JD, Pawar G, Singh GS et al. Multiple sclerosis in a
patient with chronic ulcerative colitis. Neurol India 2004;
52: 282-283.
10.Thomas CW Jr., Weinshenker BG, Sandborn WJ.
Demyelination during anti-tumor necrosis factor alpha therapy
with infliximab for Crohn's disease. Inflamm Bowel Dis
2004; 10: 28-31.
11.Do Olek MJ. Epidemiology, risk factors, and clinical features
of multiple sclerosis. In: UpToDate, Rose BD,
UpToDate, Wellesley, MA, 2004.
12.Loftus EV Jr. Clinical epidemiology of inflammatory bowel
disease: incidence, prevalence, and environmental influences.
Gastroenterology 2004; 126: 1504-17.
13.Nanavati SA, Ergun GA, Schwartz JT. Avoiding infliximab
in the treatment of Crohn's disease in patients with multiple
sclerosis. Am J Gastroenterol 2003; 98: 2333-4.
190